Bio Green Med Solution (BGMS) Free Cash Flow (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Free Cash Flow of -$279000.0 for Q1 2026, up 91.41% year-over-year from -$145762.3 in Q1 2025, and down 745.45% quarter-over-quarter from -$33000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Free Cash Flow (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Free Cash Flow for 17 consecutive years, with -$279000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 91.41% year-over-year to -$279000.0; the TTM figure through Mar 2026 stood at -$1.8 million (up 83.24% YoY), while the FY2025 annual figure was -$4.8 million, up 40.3% from the prior year.
- Free Cash Flow declined to -$279000.0 in Q1 2026 per BGMS's latest filing, from -$33000.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at -$33000.0 in Q4 2025 and bottomed at -$7.0 million in Q3 2022.
- Historically, Free Cash Flow has averaged -$2.9 million across 5 years, with a median of -$3.1 million in 2024.
- On a YoY basis, Free Cash Flow climbed as much as 97.57% in 2025 and fell as far as 572.26% in 2025.
- Bio Green Med Solution's Free Cash Flow stood at -$5.2 million in 2022, then advanced by 24.36% to -$3.9 million in 2023, then jumped by 65.32% to -$1.4 million in 2024, then surged by 97.57% to -$33000.0 in 2025, then slumped by 745.45% to -$279000.0 in 2026.
- Business Quant data shows BGMS's Free Cash Flow at -$279000.0 in Q1 2026, -$33000.0 in Q4 2025, and -$434000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.25 Bn | 133.40 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 86.50 Bn | 78.51 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.96 Bn | 59.78 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.57 Bn | 52.43 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 44.65 Bn | 44.65 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 40.37 Bn | 35.27 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.40 Bn | 32.09 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.60 Bn | 26.44 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Bio Green Med Solution | 4.87 Mn | 1.08 Mn | 79,000.00 | -352,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -352,000.00 |
| Mar 31, 2026 | -279,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Sep 30, 2025 | -434,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -3.25 Mn |
| Dec 31, 2024 | -1.36 Mn |
| Sep 30, 2024 | -3.07 Mn |
| Jun 30, 2024 | -3.08 Mn |
| Mar 31, 2024 | -483,000.00 |
| Dec 31, 2023 | -3.91 Mn |
| Sep 30, 2023 | -4.04 Mn |
| Jun 30, 2023 | -1.31 Mn |
| Mar 31, 2023 | -6.87 Mn |
| Dec 31, 2022 | -5.17 Mn |
| Sep 30, 2022 | -6.97 Mn |
| Jun 30, 2022 | -1.92 Mn |
| Mar 31, 2022 | -6.78 Mn |
| Dec 31, 2021 | -4.55 Mn |
| Sep 30, 2021 | -6.22 Mn |